Small nucleolar RNA networks are up‐regulated during human anaphylaxis

Anaphylaxis is a severe, potentially life‐threatening allergic reaction driven primarily by the activation of mast cells. We still fail to understand factors underlying reaction severity. Furthermore, there is currently no reliable diagnostic test to confirm anaphylaxis in the emergency department (ED).

[1]  R. Loeser,et al.  Small nucleolar RNAs as mediators of oxidative stress in cross species cartilage and osteoarthritis , 2020 .

[2]  M. Furia,et al.  A dynamic link between H/ACA snoRNP components and cytoplasmic stress granules. , 2019, Biochimica et biophysica acta. Molecular cell research.

[3]  Di Zhang,et al.  Targeting snoRNAs as an emerging method of therapeutic development for cancer. , 2019, American journal of cancer research.

[4]  Bixiang Zhang,et al.  Small Nucleolar RNAs: Insight Into Their Function in Cancer , 2019, Front. Oncol..

[5]  I. Cascorbi,et al.  The Nomenclature, Definition and Distinction of Types of Shock. , 2018, Deutsches Arzteblatt international.

[6]  I. Martín-Antoniano,et al.  Multi‐omics analysis points to altered platelet functions in severe food‐associated respiratory allergy , 2018, Allergy.

[7]  D. Fatovich,et al.  Serum mast cell tryptase measurements: Sensitivity and specificity for a diagnosis of anaphylaxis in emergency department patients with shock or hypoxaemia , 2018, Emergency medicine Australasia : EMA.

[8]  S. Galli,et al.  The pathophysiology of anaphylaxis. , 2017, The Journal of allergy and clinical immunology.

[9]  N. Doğan,et al.  Distributive Shock in the Emergency Department: Sepsis, Anaphylaxis, or Capillary Leak Syndrome? , 2017, The Journal of emergency medicine.

[10]  T. Takazawa,et al.  Drug‐induced anaphylaxis in the emergency room , 2017, Acute medicine & surgery.

[11]  Xin-Yuan Liu,et al.  SNORD126 promotes HCC and CRC cell growth by activating the PI3K–AKT pathway through FGFR2 , 2016, Journal of molecular cell biology.

[12]  S. Goldman,et al.  The human box C/D snoRNAs U3 and U8 are required for pre-rRNA processing and tumorigenesis , 2016, Oncotarget.

[13]  Andrew A. White,et al.  Emerging concepts: mast cell involvement in allergic diseases. , 2016, Translational research : the journal of laboratory and clinical medicine.

[14]  A. Fersht,et al.  The p53 Pathway: Origins, Inactivation in Cancer, and Emerging Therapeutic Approaches. , 2016, Annual review of biochemistry.

[15]  S. Stamm,et al.  SNORD116 and SNORD115 change expression of multiple genes and modify each other's activity. , 2015, Gene.

[16]  P. V. van Eeden,et al.  Sustained Elevation of Resistin, NGAL and IL-8 Are Associated with Severe Sepsis/Septic Shock in the Emergency Department , 2014, PloS one.

[17]  Simon G. A. Brown,et al.  Genomic Responses during Acute Human Anaphylaxis Are Characterized by Upregulation of Innate Inflammatory Gene Networks , 2014, PloS one.

[18]  T. Colombo,et al.  Growth Arrest-Specific Transcript 5 Associated snoRNA Levels Are Related to p53 Expression and DNA Damage in Colorectal Cancer , 2014, PloS one.

[19]  I. Thompson,et al.  Elevated snoRNA biogenesis is essential in breast cancer , 2014, Oncogene.

[20]  G. Isbister,et al.  Anaphylaxis: clinical patterns, mediator release, and severity. , 2013, The Journal of allergy and clinical immunology.

[21]  P. V. van Eeden,et al.  Critical illness in the emergency department: Lessons learnt from the first 12 months of enrolments in the Critical Illness and Shock Study , 2012, Emergency medicine Australasia : EMA.

[22]  S. F. Stone,et al.  Mediators Released During Human Anaphylaxis , 2012, Current Allergy and Asthma Reports.

[23]  I. Verma,et al.  Tumor Suppressor p53 Functions as a Negative Regulator in IgE-Mediated Mast Cell Activation , 2011, PloS one.

[24]  D. Metcalfe,et al.  Understanding the mechanisms of anaphylaxis , 2008, Current opinion in allergy and clinical immunology.

[25]  D. Hepner,et al.  Second symposium on the definition and management of anaphylaxis: summary report--Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. , 2006, The Journal of allergy and clinical immunology.

[26]  S. Brown.  Clinical features and severity grading of anaphylaxis. , 2004, The Journal of allergy and clinical immunology.

[27]  B. Long,et al.  Clinical Mimics: An Emergency Medicine-Focused Review of Sepsis Mimics. , 2017, The Journal of emergency medicine.

[28]  Miguel Park,et al.  Outcomes of allergy/immunology follow-up after an emergency department evaluation for anaphylaxis. , 2015, The journal of allergy and clinical immunology. In practice.